Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia von RAVANDI, Farhad, CORTES, Jorge E, PIERCE, Sherry R, BRANDT, Mark, BYRD, Anna, NEBIYOU BEKELE, B, PRATZ, Keith, LUTHRA, Rajyalakshmi, LEVIS, Mark, ANDREEFF, Michael, KANTARJIAN, Hagop M, JONES, Daniel, FADERL, Stefan, GARCIA-MANERO, Guillermo, KONOPLEVA, Marina Y, O'BRIEN, Susan, ESTROV, Zeev, BORTHAKUR, Gautam, THOMAS, Deborah

Volltext

Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome von Garcia-Manero, Guillermo, Tambaro, Francesco Paolo, Bekele, Nebiyou B, Yang, Hui, Ravandi, Farhad, Jabbour, Elias, Borthakur, Gautam, Kadia, Tapan M, Konopleva, Marina Y, Faderl, Stefan, Cortes, Jorge E, Brandt, Mark, Hu, Yumin, McCue, Deborah, Newsome, Willie Mae, Pierce, Sherry R, de Lima, Marcos, Kantarjian, Hagop M

Volltext

Significance of FAB subclassification of “acute myeloid leukemia, NOS” in the 2008 WHO classification: analysis of 5848 newly diagnosed patients von Walter, Roland B., Othus, Megan, Burnett, Alan K., Löwenberg, Bob, Kantarjian, Hagop M., Ossenkoppele, Gert J., Hills, Robert K., van Montfort, Kees G.M., Ravandi, Farhad, Evans, Anna, Pierce, Sherry R., Appelbaum, Frederick R., Estey, Elihu H.

Volltext

Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes von Montalban-Bravo, Guillermo, Kanagal-Shamanna, Rashmi, Benton, Christopher B., Class, Caleb A., Chien, Kelly S., Sasaki, Koji, Naqvi, Kiran, Alvarado, Yesid, Kadia, Tapan M., Ravandi, Farhad, Daver, Naval, Takahashi, Koichi, Jabbour, Elias, Borthakur, Gautham, Pemmaraju, Naveen, Konopleva, Marina, Soltysiak, Kelly A., Pierce, Sherry R., Bueso-Ramos, Carlos E., Patel, Keyur P., Kantarjian, Hagop, Garcia-Manero, Guillermo

Volltext

Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis von Boddu, Prajwal, Kantarjian, Hagop M., Garcia-Manero, Guillermo, Ravandi, Farhad, Verstovsek, Srdan, Jabbour, Elias, Borthakur, Gautam, Konopleva, Marina, Bhalla, Kapil N., Daver, Naval, DiNardo, Courtney D., Benton, Christopher B., Takahashi, Koichi, Estrov, Zeev, Pierce, Sherry R., Andreeff, Michael, Cortes, Jorge E., Kadia, Tapan M.

Volltext

Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents von Hammond, Danielle, Loghavi, Sanam, Wang, Sa A., Konopleva, Marina Y., Kadia, Tapan M., Daver, Naval G., Ohanian, Maro, Issa, Ghayas C., Alvarado, Yesid, Short, Nicholas J., Sasaki, Koji, Pemmaraju, Naveen, Montalban-Bravo, Guillermo, Lachowiez, Curtis A., Maiti, Abhishek, Garcia-Manero, Guillermo, Jabbour, Elias J., Borthakur, Gautam, Ravandi, Farhad, Takahashi, Koichi, Pierce, Sherry R., Kantarjian, Hagop M., DiNardo, Courtney D.

Volltext

Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens von Lachowiez, Curtis A., Loghavi, Sanam, Kadia, Tapan M., Daver, Naval, Borthakur, Gautam, Pemmaraju, Naveen, Naqvi, Kiran, Alvarado, Yesid, Yilmaz, Musa, Short, Nicholas, Ohanian, Maro, Pierce, Sherry R., Patel, Keyur P., Qiao, Wei, Ning, Jing, Sasaki, Koji, Takahashi, Koichi, Jabbour, Elias, Andreeff, Michael, Ravandi, Farhad, Kantarjian, Hagop M., Konopleva, Marina, DiNardo, Courtney D.

Volltext

Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid... von Badar, Talha, Kantarjian, Hagop M, Ravandi, Farhad, Jabbour, Elias, Borthakur, Gautam, Cortes, Jorge E, Pemmaraju, Naveen, Pierce, Sherry R, Newberry, Kate J, Daver, Naval, Verstovsek, Srdan

Volltext

The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations von Appelbaum, Frederick R., Kopecky, Kenneth J., Tallman, Martin S., Slovak, Marilyn L., Gundacker, Holly M., Kim, Haesook T., Dewald, Gordon W., Kantarjian, Hagop M., Pierce, Sherry R., Estey, Elihu H.

Volltext

Safety and clinical activity of 5‐aza‐2′‐deoxycytidine (decitabine) with or without Hyper‐CVAD in relapsed/refractory acute lymphocytic leukaemia von Benton, Christopher B., Thomas, Deborah A., Yang, Hui, Ravandi, Farhad, Rytting, Michael, O'Brien, Susan, Franklin, Anna R., Borthakur, Gautam, Dara, Samuel, Kwari, Monica, Pierce, Sherry R., Jabbour, Elias, Kantarjian, Hagop, Garcia‐Manero, Guillermo

Volltext

Clinical value of event-free survival in acute myeloid leukemia von Maiti, Abhishek, Kantarjian, Hagop M., Popat, Vinita, Borthakur, Gautam, Garcia-Manero, Guillermo, Konopleva, Marina Y., DiNardo, Courtney D., Verstovsek, Srdan, Andreeff, Michael, Kadia, Tapan M., Ajufo, Helen O., Goswamy, Rohit V., Blanco, Carlos, Velasquez, Miguel, Daver, Naval G., Pemmaraju, Naveen, Pierce, Sherry R., Wierda, William G., Kornblau, Steven M., Ravandi, Farhad, Cortes, Jorge E.

Volltext

Topotecan and Cytarabine Is an Active Combination Regimen in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia von BERAN, M, ESTEY, E, HAYES, K, GEE CHUAN WONG, KEATING, M, KANTARJIAN, H, O'BRIEN, S, CORTES, J, KOLLER, C. A, GILES, F. J, KORNBLAU, S, ANDREEFF, M, VEY, N, PIERCE, S. R

Volltext

Association Between RUNX3 Hypermethylation and Acute Myeloid Leukemia Inv(16) Subtype von Estecio, Marcos R, Maddipoti, Sirisha, DiNardo, Courtney D., Yang, Hui, Stevenson, William S, Bueso-Ramos, Carlos E., Pierce, Sherry R., Wei, Yue, Garcia-Manero, Guillermo

Volltext

Therapeutic Benefit of Decitabine, a Hypomethylating Agent, in Patients with Myeloproliferative Neoplasm in Blastic Phase/Acute Myeloid Leukemia (MPN-AML), Accelerated Phase (MPN-A... von Badar, Talha, Kantarjian, Hagop M., Ravandi, Farhad, Jabbour, Elias, Borthakur, Gautam, Cortes, Jorge E., Pemmaraju, Naveen, Pierce, Sherry R., Daver, Naval, Verstovsek, Srdan

Volltext

Outcome of Patients (pts) with Therapy-Related De Novo Acute Myeloid Leukemia (t-de novo AML): Single Institution Experience von Sasaki, Koji, Jabbour, Elias, Kantarjian, Hagop M., Cortes, Jorge E., Garcia-Manero, Guillermo, Borthakur, Gautam, Pierce, Sherry R., Pemmaraju, Naveen, O’Brien, Susan, Ravandi, Farhad

Volltext

Chronic Myeloid Leukemia in Chronic Phase: Survival in the Era of Tyrosine Kinase Inhibitors Is Similar to That of the General Population in All Age Groups von Sasaki, Koji, Strom, Sara S., O’Brien, Susan, Jabbour, Elias, Ravandi, Farhad, Konopleva, Marina, Borthakur, Gautam, Pemmaraju, Naveen, Daver, Naval, Pierce, Sherry R., Kantarjian, Hagop M., Cortes, Jorge E.

Volltext

Incidence Of and Risk Factors For Acute Myeloid Leukemia Involvement Of The Central Nervous System von Uri, Rozovski, Ohanian, Maro, Ravandi, Farhad, Garcia-Manero, Guillermo, Faderl, Stefan H., Cortes, Jorge E., Pierce, Sherry R., Hagop, Kantarjian, Estrov, Zeev

Volltext

Survival Outcomes In Relapsed/Refractory Acute Myeloid Leukemia Patients Who Achieve Less-Than-Complete Response After Salvage Therapy von Shah, Shilpan S., Kantarjian, Hagop M, Ravandi, Farhad, O'Brien, Susan, Garcia-Manero, Guillermo, Andreeff, Michael, Konopleva, Marina, Jabbour, Elias, Pierce, Sherry R., Borthakur, Gautam, Cortes, Jorge E.

Volltext

Resistance Prediction in AML: Analysis of 4,601 Patients from MRC/NCRI, HOVON/SAKK, SWOG, and MD Anderson Cancer Center von Walter, Roland B., Othus, Megan, Burnett, Alan K., Löwenberg, Bob, Kantarjian, Hagop M., Ossenkoppele, Gert J., Hills, Robert K., Ravandi, Farhad, Pabst, Thomas, Evans, Anna, Pierce, Sherry R., Vekemans, Marie-Christiane, Appelbaum, Frederick R., Estey, Elihu H.

Volltext

Impact Of Cytarabine Dose In The Induction Regimen On The Outcome Of Patients With Newly Diagnosed Acute Myeloid Leukemia With Or Without NPM1 and/Or FLT3 Mutations: A SWOG and MD... von Ravandi, Farhad, Othus, Megan, Faderl, Stefan H., Stirewalt, Derek L., Pierce, Sherry R., Borthakur, Gautam, Godwin, John, Anderson, Jeanne E., Petersdorf, Stephen, Cortes, Jorge E., Ostronoff, Fabiana, Pogosova-Agadijanyan, Era, Appelbaum, Frederick R., Kantarjian, Hagop M., Estey, Elihu H.

Volltext